sera – Page 36 – Communicable Diseases Research

Investigation of the impact of SARS-CoV infection on the immunologic status and lung function after 15 years

15 년 후 면역 상태 및 폐 기능에 대한 SARS-COV 감염의 영향에 대한 조사

Research

Published on 2021-11-242022-09-01
Journal: BMC Infectious Diseases [Category] MERS, SARS, 임상, 진단, 치료기술,

Correlates of neutralizing/SARS-CoV-2-S1-binding antibody response with adverse effects and immune kinetics in BNT162b2-vaccinated individuals

BNT162B2- 암시 처리 된 개체에서 부작용 및 면역 동역학과의 중화/SARS-COV-2-S1- 결합 항체 반응의 상관 관계

Article

Published on 2021-11-242022-09-01
Journal: Scientific Reports [Category] MERS, SARS, 변종, 진단, 치료기술,

Antibodies specific to SARS-CoV-2 proteins N, S and E in COVID-19 patients in the normal population and in historical samples

정상 인구 및 과거 샘플의 COVID-19 환자에서 SARS-CoV-2 단백질 N, S 및 E에 특이적인 항체

Animal

Published on 2021-11-242022-09-10
Journal: The Journal of General Virology [Category] MERS, SARS, 진단, 치료법,

[키워드] acquired immunity acute respiratory syndrome acute respiratory syndrome coronavirus analysed antibodies antibody Antibody Response can not circulation coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient diagnostic domain envelope protein epidemiological healthy IgA IgA levels IgG IgG level immune response immune responses immunology Infection inhibit SARS-CoV-2 Kinetics nucleocapsid protein other coronavirus other coronaviruses pandemic Patient preserved Protective protective role Recognition respiratory SARS-CoV-2 SARS-CoV-2 protein sera severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 Spike protein Spread target the SARS-CoV-2 Treatment virus virus-neutralizing
[DOI] 10.1099/jgv.0.001692 PMC 바로가기 [Article Type] Animal

High SARS-CoV-2 Seroprevalence in Rural Peru, 2021: a Cross-Sectional Population-Based Study

페루 농촌의 높은 SARS-CoV-2 혈청 유병률, 2021: 횡단면 인구 기반 연구

Observation

Published on 2021-11-242022-09-10
Journal: mSphere [Category] MERS, SARS, 진단, 치료기술,

[키워드] 95% CI 95% confidence interval Affect affected Algorithm altitude Antibody testing avoidance Care chemiluminescence immunoassay CLIA correlations COVID-19 COVID-19 pandemic cross-sectional diagnostics enrolled evade Factor false-positive result False-positive results Health Health care highlighting hot spot incidence Infection information Latin Latin America lead mandatory measure neutralization test performed Peru Population population density Population size populations public health quarantine reactive Region regions reported rural rural population Rural populations SARS-CoV-2 SARS-CoV-2 antibody testing SARS-CoV-2 IgG antibodies SARS-CoV-2 IgG antibody Screening sera serologic serological serology Seroprevalence Spearman specificity Spread Support surface area Surveillance surveillance data sVNT tropical Vaccination strategies Vaccination strategy validation virus neutralization test was done
[DOI] 10.1128/mSphere.00685-21 PMC 바로가기 [Article Type] Observation

Safety and Seroconversion of Immunotherapies against SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis of Clinical Trials

Systematic Review

Published on 2021-11-242022-10-28
Journal: Pathogens [Category] COVID-19,

[키워드] 95% CI active immunity acute respiratory syndrome adverse event AEs Analysis Antibody Response clinical clinical trial clinical trials components conducted Controlled Coronavirus disease 2019 (COVID-19) Coronavirus-2 defined Efficacy enrolled evaluate healthy Heterologous heterologous immunity host immunity immune response Immunity immunological Immunotherapy inactivated Infection injected inoculated Intervention involved mechanism meta-analyses Meta-analysis neutralize Odds ratio participant passive immunity populations pre-vaccination Prophylactic Protein random-effect Registered review RNA Safety SARS-CoV-2 searched sera Seroconversion severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) systemic adverse event systemic AE therapeutic Treatment Trial trials vaccination Vaccine Vaccines Viral vector viral vector-based virus was used
[DOI] 10.3390/pathogens10121537 PMC 바로가기 [Article Type] Systematic Review

Seroprevalence of anti-SARS-CoV-2 antibodies in women attending antenatal care in eastern Ethiopia: a facility-based surveillance

에티오피아 동부의 산전 치료에 참석하는 여성의 항 -SARS-COV-2 항체의 혈청 유병률 : 시설 기반 감시

Epidemiology

Published on 2021-11-242022-09-01
Journal: BMJ Open [Category] Fulltext, MERS, SARS, 진단,

[키워드] 95% CI analysed antenatal care anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody blood sample Blood samples collected conducted COVID-19 dynamic Epidemic Harar Health Health policy hospital Immunoglobulin Infection infection control Laboratory linear mother multivariable multivariable model objective one health participant positive pregnant pregnant women prenatal diagnosis protocols & guidelines questionnaire data random Rapid Rapid test reached remained Result SARS-CoV-2 SARS-CoV-2 epidemic selected sera seropositive Seroprevalence setting Spread Surveillance susceptible Test tested the SARS-CoV-2 women
[DOI] 10.1136/bmjopen-2021-055834 PMC 바로가기 [Article Type] Epidemiology

Evaluation of the Relationship between Clonal Hematopoiesis and Severe COVID-19 Disease in Rhesus Macaques

Conference abstract

Published on 2021-11-242022-10-05
Journal: Blood [Category] 변종,

[키워드] Acquired advanced age age Analysis Asymptomatic autologous Autopsy BAL benefit Blood clinical manifestation clinical symptom clinically co-morbidities cohort study Concentration Control control group controls COVID-19 COVID-19 disease detectable develop died disease Evidence expand Factor Genes group hallmark Hematopoiesis Human Hyperinflammatory IL-6 IL-6 level IL-8 Infection Inflammation inoculated Laboratory LOF loss of function lung tissue macaque MCP-1 Mild MIP-1b Multiorgan mutant Mutation occur pathophysiological pathophysiology phenotype progenitor cell relationship reported Respiratory failure Respiratory samples rhesus macaque risk risk factor robust Sample size SARS-CoV infection SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 RNA sera severe COVID-19 severe COVID-19 disease severe COVID-19 illness significant difference somatic mutation suggested Symptom TET2 the median therapeutic approaches therapy Vaccine development Viral antigen
[DOI] 10.1182/blood-2021-152628 [Article Type] Conference abstract

Long-Term Humoral Immune Response against SARS-CoV-2 after Natural Infection and Subsequent Vaccination According to WHO International Binding Antibody Units (BAU/mL)

WHO 국제 결합 항체 유닛 (BAU/mL)에 따른 자연 감염 후 SARS-COV-2에 대한 장기 체액 면역 반응

Article

Published on 2021-11-232022-09-01
Journal: Viruses [Category] MERS, SARS, 진단, 치료법,

[키워드] anti-SARS-CoV-2 antibodies antibody Antibody Units BAU binding antibody unit binding antibody units boost collected Concentration Course COVID-19 cut-off Definition Effect elevated ELISA evaluated examined expected IgA IgG Immune status individuals infection with SARS-CoV-2 Mild MOST mRNA vaccine N-protein natural natural infection neutralize Patient patients reference standard remained response retained SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV-2 antigens SARS-CoV-2 N-protein SARS-CoV-2 S1-RBD-protein SARS-CoV-2 WHO standard sequence sera serum antibodies serum antibody Serum Neutralization serum sample serum samples the antibody the WHO unit vaccination WHO
[DOI] 10.3390/v13122336 PMC 바로가기 [Article Type] Article

Persistence of the Immune Responses and Cross-Neutralizing Activity With Variants of Concern Following 2 Doses of Adjuvanted SCB-2019 Coronavirus Disease 2019 Vaccine

Article

Published on 2021-11-222022-11-15
Journal: The Journal of Infectious Diseases [Category] SARS, 변종, 진단,

Pre-Existing Cross-Reactive Antibody Responses Do Not Significantly Impact Inactivated COVID-19 Vaccine-Induced Neutralization

기존 교차 반응성 항체 반응은 비활성화된 COVID-19 백신 유도 중화에 큰 영향을 미치지 않습니다

Immunology

Published on 2021-11-192022-09-12
Journal: Frontiers in Immunology [Category] MERS, SARS, 진단,

[키워드] acute respiratory syndrome analyzed antibody Antibody Response collected conserved CoV COVID-19 COVID-19 vaccine cross-reactive antibody cross-reactive antibody immunity distribution dose epitope Evidence fluorescence intensity greater healthy volunteer Humoral immunity IgG and IgM Immunity immunization Impact inactivated Inactivated vaccine increase in intensity linear neutralization not differ participant peptide peptides pre-vaccination previous study produced Protective provide recent Region Research response responses responses against S2 subunit SARS-CoV-2 SARS-CoV-2 vaccine seasonal coronavirus sera significantly stimulate the S protein vaccinee whole-virion SARS-CoV-2 vaccine
[DOI] 10.3389/fimmu.2021.772511 PMC 바로가기 [Article Type] Immunology